Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.
Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Hjalte Hojsgaard, Insulet International, highlights why choice of insulin delivery devices is important, and why access to this life-changing technology is not yet fully utilised in UK diabetes services.
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.
Max Halford FBDO CL, Clinical Lead for the Association of British Dispensing Opticians, tells us what we need to know about Diabetic Retinal Screening in this eye health focus.
Professor Lina Badimon and Elisabetta Zanon from the European Society of Cardiology provide their thoughts on understanding and addressing the impact of COVID-19 on heart disease.
